These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26723976)

  • 1. Cabazitaxel causes a dose-dependent central nervous system toxicity in rats.
    Karavelioglu E; Gonul Y; Aksit H; Boyaci MG; Karademir M; Simsek N; Guven M; Atalay T; Rakip U
    J Neurol Sci; 2016 Jan; 360():66-71. PubMed ID: 26723976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cabazitaxel's ototoxicity: An animal study and histopathologic research.
    Bucak A; Özdemir Ç; Kınar A; Ulu Ş; Kuzu S; Günebakan Ç; Kahveci OK
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.
    Vrignaud P; Sémiond D; Lejeune P; Bouchard H; Calvet L; Combeau C; Riou JF; Commerçon A; Lavelle F; Bissery MC
    Clin Cancer Res; 2013 Jun; 19(11):2973-83. PubMed ID: 23589177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.
    Sémiond D; Sidhu SS; Bissery MC; Vrignaud P
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):515-28. PubMed ID: 23820961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis.
    Ghoochani A; Hatipoglu Majernik G; Sehm T; Wach S; Buchfelder M; Taubert H; Eyupoglu IY; Savaskan N
    Oncotarget; 2016 Jun; 7(25):38306-38318. PubMed ID: 27203678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
    de Bono JS; Oudard S; Ozguroglu M; Hansen S; Machiels JP; Kocak I; Gravis G; Bodrogi I; Mackenzie MJ; Shen L; Roessner M; Gupta S; Sartor AO;
    Lancet; 2010 Oct; 376(9747):1147-54. PubMed ID: 20888992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cabazitaxel in patients with advanced solid tumours: results of a Phase I and pharmacokinetic study.
    Diéras V; Lortholary A; Laurence V; Delva R; Girre V; Livartowski A; Assadourian S; Semiond D; Pierga JY
    Eur J Cancer; 2013 Jan; 49(1):25-34. PubMed ID: 22975213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain Disposition and Oral Availability of the Novel Taxane Cabazitaxel (Jevtana) in Mice.
    Tang SC; Kort A; Cheung KL; Rosing H; Fukami T; Durmus S; Wagenaar E; Hendrikx JJ; Nakajima M; van Vlijmen BJ; Beijnen JH; Schinkel AH
    Mol Pharm; 2015 Oct; 12(10):3714-23. PubMed ID: 26317243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.
    Bracarda S; Gernone A; Gasparro D; Marchetti P; Ronzoni M; Bortolus R; Fratino L; Basso U; Mazzanti R; Messina C; Tucci M; Boccardo F; Cartenì G; Pinto C; Fornarini G; Mattioli R; Procopio G; Chiuri V; Scotto T; Dondi D; Di Lorenzo G
    Future Oncol; 2014 May; 10(6):975-83. PubMed ID: 24295376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cabazitaxel--a next-generation taxane for the treatment of patients with metastatic castration-resistant prostate cancer].
    Ecstein-Fraisse E; Su Z
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):817-22. PubMed ID: 25131866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium protects cerebral cells by cisplatin induced neurotoxicity.
    Karavelioglu E; Boyaci MG; Simsek N; Sonmez MA; Koc R; Karademir M; Guven M; Eser O
    Acta Cir Bras; 2015 Jun; 30(6):394-400. PubMed ID: 26108027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cabazitaxel: more than a new taxane for metastatic castrate-resistant prostate cancer?
    Mita AC; Figlin R; Mita MM
    Clin Cancer Res; 2012 Dec; 18(24):6574-9. PubMed ID: 23091116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.
    Wissing MD; Coenen JL; van den Berg P; Westgeest HM; van den Eertwegh AJ; van Oort IM; Bos MM; Bergman AM; Hamberg P; Ten Tije AJ; Los M; Lolkema MP; de Wit R; Gelderblom H
    Int J Cancer; 2015 Mar; 136(6):E760-72. PubMed ID: 25242736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme.
    Heidenreich A; Bracarda S; Mason M; Ozen H; Sengelov L; Van Oort I; Papandreou C; Fossa S; Hitier S; Climent MA;
    Eur J Cancer; 2014 Apr; 50(6):1090-9. PubMed ID: 24485664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy.
    Evans TL; Cho BC; Udud K; Fischer JR; Shepherd FA; Martinez P; Ramlau R; Syrigos KN; Shen L; Chadjaa M; Wolf M
    J Thorac Oncol; 2015 Aug; 10(8):1221-8. PubMed ID: 26200278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel.
    Fernández O; Afonso J; Vázquez S; Campos B; Lázaro M; León L; Antón Aparicio LM
    Anticancer Drugs; 2014 Mar; 25(3):237-43. PubMed ID: 24217332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral olfactory sensitivity in rodents after treatment with docetaxel.
    Faure F; Da Silva SV; Jakob I; Pasquis B; Sicard G
    Laryngoscope; 2010 Apr; 120(4):690-7. PubMed ID: 20205251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cabazitaxel in metastatic castration-resistant prostate cancer.
    Yap TA; Pezaro CJ; de Bono JS
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1129-36. PubMed ID: 23098113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional influences of acetazolamide on central nervous system oxygen toxicity of rats.
    Huang JL; Zhang YL; Xiao X; Zhang JH; Lian QL; Liu Y; Sun XJ
    Undersea Hyperb Med; 2010; 37(5):271-80. PubMed ID: 20929184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer.
    Ramachandran K; Speer C; Nathanson L; Claros M; Singal R
    Anticancer Res; 2016 Jan; 36(1):161-8. PubMed ID: 26722040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.